Home > Healthcare > Biotechnology > Biotechnology R&D > Gene Editing Market

Gene Editing Market Size

Report ID: GMI810
Published Date: May 2022
Report Format: PDF

Download Free Sample

Gene Editing Market Size

Gene Editing Market size surpassed USD 5.4 Bn in 2021 and is expected to witness a 15.5% CAGR from 2022 to 2030 owing to an increasing technological advancement driven by the rapidly evolving CRISPR technology with its wide range of applications for gene editing.

To get key market trends

Download Free Sample

This technology is mainly used to gain accessibility of genetically modified crops by delivering gene editing reagents in the plants. Moreover, this technology is also accessible for genetically modified animals with application for agricultural purposes and biomedical fields.

The impact of COVID-19 on the gene editing market share is observed to be positive. Recently, in 2020, SHERLOCK CRISPR SARS-CoV-2 test kit was granted by Emergency Use Authorization from the FDA. This is due to the programming by CRISPR for detecting genetic pattern of SARS-CoV-2 by utilising gRNA. In case target is detected in a sample, the CRISPR is activated and released.

Gene Editing or genome editing is mainly used to change an organism’s DNA by various group of technologies. This method allows genetic material to be replaced, added, or removed at spotted locations in the genome. Therefore, various editing approaches have been developed for its application in the industry. Gene editing is also used for prevention and treatment of human diseases such as cystic fibrosis, sickle cell diseases, HIV infection, cancer, and others.

Gene Editing Market Report Attributes
Report Attribute	Details
Base Year:	2021
Gene Editing Market Size in 2021:	USD 5.5 Billion
Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	15.5%
2030 Value Projection:	USD 20 Billion
Historical Data for:	2017 to 2021
No. of Pages:	130
Tables, Charts & Figures:	117
Segments covered:	Application, Technology, End-user, and Region
Growth Drivers:	Increased funding for genetic research in North America Rising R&D expenditure and growth of biotechnology in Europe Increasing demand for synthetic genes in Asia Pacific and North America Technology advancements in gene editing in North America
Pitfalls & Challenges:	Stringent government regulations Lack of public awareness in underdeveloped economies

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The gene editing industry is slated to surpass USD 19.9 billion by 2030 and is poised to record a 15.5% CAGR from 2022 to 2030 on account of the rise in technological advancements and the rapidly evolving CRISPR technology.

The CRISPR/Cas9 technology segment in the gene editing market is poised to record a 15.6% CAGR through 2030 owing to its benefits, including simplicity, easy use, and affordability.

The biotech and pharma companies end-user segment captured close to 45.5% of the gene editing market share in 2021 due to the rising focus on the development of new gene editing technologies.

The gene editing industry revenue from the cell line engineering application segment had crossed USD 2.2 billion in 2021 due to the swift developments and advancements in genome editing technologies.

North America held more than 38% of the gene editing industry share in 2021 and will record a significant CAGR through 2030 due to the higher burden of rare diseases in the U.S. and Canada.